Trial of Preemptive Pharmacogenetics in Underserved Patients
Running, not enrolling · Not applicable
Conditions studied: Use of Prescription Medications, Pharmacogenetic Testing
In brief
This proposed research is relevant to human health because preemptive clinical pharmacogenetic testing may improve the personalization of drug therapy which should improve patient outcomes. Better understanding of the effectiveness and feasibility of preemptive clinical pharmacogenetic testing will inform when and how this innovative healthcare technology is implemented into clinical care. To ensure equitable dissemination in all patient populations, such data is also needed in racial minorities and other traditionally underserved populations. The combined proposed research are relevant to the parts of the NIH's mission pertaining to protecting and improving health and developing scientific human resources that will ensure the Nation's capability to prevent and treat disease.
Key facts
- Study ID
- NCT05141019
- Run by
- University of Florida
- People needed
- 492
- Starts
- 2022-08-01
- Expected to finish
- 2026-06-30
- Last updated by the study team
- 2025-11-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adults > 18 years of age
- at least 3 active prescriptions documented within medical records
- Experienced a change to an active prescription within the past 8 months, defined by:
- Addition of a new medication
- Change in the dose of a current medication
- Diagnosis of any condition that could be treated with a medication that can be informed by the pharmacogenetic testing panel.
- This will likely include:
- generalized depression or anxiety disorder
- gastroesophageal reflux disorder
- erosive esophagitis
- gastric ulcer
- acute coronary syndrome
- chronic pain
- surgery (orthopedic, gastrointestinal, cardiovascular etc.)
- osteoarthritis
- Dyslipidemia
- Heart failure
- Deep vein thrombosis
- Atrial fibrillation
- Moderate to severe trauma
- stroke
- hypercholesterolemia
- conditions requiring chronic anticoagulation
You may not qualify if…
- Any history of previous pharmacogenetic testing
- Any medical condition that would prohibit the ability to answer study questions
- History of Allogenic stem cell or liver transplant
- History of chronic kidney dialysis
- Life expectancy less than 12 months
Where it is running
- UF Health at the University of Florida — Gainesville, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.